Aberrant A2A receptor function in peripheral blood cells in Huntington's disease

Area of Science:

• Neuroscience
• Genetics
• Pharmacology

Background:

• A2A adenosine receptors on striatal neurons are crucial for motor control and implicated in neurodegenerative disorders.
• Huntington's disease (HD) involves cortico-striatal pathway imbalance due to HD gene mutations, potentially affecting striatal cells.
• Previous studies showed A2A receptor dysfunction in engineered cells expressing mutant huntingtin.

Purpose of the Study:

• To investigate if A2A adenosine receptor binding and function are altered in peripheral blood cells of individuals with the Huntington's disease gene mutation.
• To determine if these peripheral changes correlate with disease status or risk.

Main Methods:

• Compared A2A receptor density and function in platelets, lymphocytes, and neutrophils from 48 heterozygous HD patients, 3 homozygous HD patients, 7 at-risk mutation carriers, and 58 healthy controls.
• Assessed binding and functional parameters of A2A adenosine receptors.

Main Results:

• A2A receptor density and function were significantly increased in peripheral blood cells of both HD patients and presymptomatic at-risk individuals.
• Homozygous HD subjects exhibited higher receptor dysfunction in neutrophils compared to heterozygotes.
• An aberrant A2A receptor phenotype was identified in peripheral blood cells carrying the HD mutation.

Conclusions:

• Peripheral blood cells from individuals with the Huntington's disease mutation display an abnormal A2A receptor phenotype.
• This aberrant A2A receptor characteristic is present even at the presymptomatic stage.
• Further research is warranted to explore the potential of this parameter as a peripheral biomarker for Huntington's disease.